Get started
Author

Chris T.P. Do

Observed names: Chris TP Do, Chris TP. Do
ORCID: 0000-0001-6694-853X
Observed ORCID: 0000-0001-6694-853X
OpenAlex ID: A5084082668
The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects
2024 · Chris TP Do, Jack Y Prochnau, et al. · Biomedicines · 10
Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2025 · Deepika Singh, Benjamin C. Onyeagucha, et al. · Cancer Research · 1
Figure SI6 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Table S1B from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Table S1A from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Data from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Figure SI5 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Figure SI1 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Figure SI3 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Figure SI2 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Figure SI4 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
2026 · Deepika Singh, Benjamin C. Onyeagucha, et al.
Figure S2 from Targeting DDR2 for Treating Pancreatic Cancer
2025 · Chris T.P. Do, Prabhakar Pitta Venkata, et al.
PDF
Figure S1 from Targeting DDR2 for Treating Pancreatic Cancer
2025 · Chris T.P. Do, Prabhakar Pitta Venkata, et al.
PDF
Data from Targeting DDR2 for Treating Pancreatic Cancer
2025 · Chris T.P. Do, Prabhakar Pitta Venkata, et al.
Figure S4 from Targeting DDR2 for Treating Pancreatic Cancer
2025 · Chris T.P. Do, Prabhakar Pitta Venkata, et al.
PDF
Supplementary Tables 1-4 from Targeting DDR2 for Treating Pancreatic Cancer
2025 · Chris T.P. Do, Prabhakar Pitta Venkata, et al.
PDF
Figure S3 from Targeting DDR2 for Treating Pancreatic Cancer
2025 · Chris T.P. Do, Prabhakar Pitta Venkata, et al.
PDF
Abstract B030: Targeting DDR2 for Treating Pancreatic Cancer
2025 · Chris TP. Do, Stanton McHardy, et al. · Cancer Research
Targeting DDR2 for Treating Pancreatic Cancer
2025 · Chris T.P. Do, Prabhakar Pitta Venkata, et al. · Molecular Cancer Therapeutics
Works count: 19
Citation count: 11
H-index: 1
I10-index: 1
Year
Topic
Type